Tag Archives: Obesity Medications

24

Jan

Obesity Medication Update

Posted In: Pharmacology By Craig Primack MD FACP

Anti-obesity medications are FDA approved for patients who have a BMI over 30 and for patients who have a BMI over 27 if they also have a weight related medical condition, like high blood pressure, high cholesterol, type 2 diabetes mellitus or sleep apnea. I also use medication if a patient has obesity based on body fat percentage, which is generally accepted to be >32% for women and >25% for men. [Read more]

24

Jan

One of the most common diseases treated in our obese/overweight populations is Diabetes. Why are we hesitant to using Metformin early? Early use of Metformin has been a topic for years with the US Diabetes Prevention Program (DPP) results and the follow-up DPP Outcomes Study (DPPOS). Both of these studies have shown the decrease in the prevalence of diabetes developing with the addition of metformin. Combined with lifestyle modifications, results were even better. [Read more]

Phentermine was approved for use in 1959 and for a period of 12 weeks. As obesity has been identified as a chronic disease, the long term use of phentermine has become mainstream amongst physicians who practice full-time obesity medicine. 97% of obesity medicine specialists indicate phentermine is their drug of choice among the current medication options available. Reasons for this include efficacy, safety, tolerability, low cost and low addiction potential. Despite this, concerns regarding safety and addiction potential have continued to limit the use by some physicians. [Read more]